Combined radiotherapy and immunotherapy to treat cancer
CA 2244841 A1 · Owner: Mcbride, William H. · Inventors: Mcbride, William H.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a method of increasing the susceptibility of a tumor in a mammalian subject to the effects of radiation therapy by contacting the tumor with a cytokine or a nucleic acid molecule encoding a cytokine. The invention also provides a method of increasing the susceptibility of a tumor in a mammalian subject to the effects of radiation therapy by administering at a site other than the tumor, a cell genetically modified to express a cytokine. The invention further provides a method of reducing the severity of a cancer in a subject by administering a cytokine at the site of the tumor or by immunizing the subject at a site other than the tumor with tumor cells …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 31, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 31, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 31, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.